Respiratory Review of 2013: Pulmonary Thromboembolism / 결핵및호흡기질환
Tuberculosis and Respiratory Diseases
;
: 89-94, 2013.
Artículo
en Inglés
| WPRIM
| ID: wpr-74266
ABSTRACT
Pulmonary embolism (PE), which can originate as a consequence of deep vein thrombosis (DVT), is the most frequent and potentially fatal venous thromboembolic event. Despite the fact that the incidence of venous thromboembolism (VTE) in Asians is lower than that in the Western populations, a recent epidemiologic study demonstrates an increasing incidence of VTE in the Korean population. Anticoagulants, including low molecular weight heparin (LMWH) and vitamin K antagonist (VKAs), have been the main treatments for PE, however, recently new oral anticoagulants (NOACs) were introduced. We will review how well patients with PE can be managed with the existing anticoagulants and NOACs along with the time span of treatment, which still pose some challenges for clinicians.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Embolia Pulmonar
/
Vitamina K
/
Incidencia
/
Heparina de Bajo-Peso-Molecular
/
Trombosis de la Vena
/
Pueblo Asiatico
/
Tromboembolia Venosa
/
Anticoagulantes
Tipo de estudio:
Estudio de incidencia
/
Estudio pronóstico
Límite:
Humanos
Idioma:
Inglés
Revista:
Tuberculosis and Respiratory Diseases
Año:
2013
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS